Pharmaceutical Industry

Page 88 of 100

Allergan Inc.'s Botox Cosmetic As Actavis Plc Buys Drugmaker For $66 Billion
Health

When Viagra met Botox: Pfizer, Allergan eye mega-merger

By
October 29, 2015
Cholesterol lowering pill
Health

This drug will make your flu shot less effective

By
October 29, 2015
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Finance

Valeant accounting scandal: 4 critical questions that have been left unanswered

By
October 26, 2015
Why the drug price scandal won’t be enough to keep down prices
Retail

Why the drug price scandal won’t be enough to keep down prices

By
October 26, 2015
Imprimis Turing Drug
Health

This company is offering a $1 alternative to Turing’s $750 drug

By
October 23, 2015
MSMB Capital Management CIO Martin Shkreli
Health

This super-expensive drug is getting a $1 rival

By
October 23, 2015
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Finance

Valeant short seller on pharmacy alliance: It’s the ‘turd in the punch bowl’

By
October 22, 2015
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., waits for the start of their annual general meeting in Laval, Quebec
Finance

Valeant’s accounting problems: It gets worse

By
October 22, 2015
Big pharma won’t stay silent in drug pricing debate for long
Health

Big pharma won’t stay silent in drug pricing debate for long

By
October 22, 2015
New Reasearch Shows That Aspirin May Cut Breast Cancer Risk
Health

The world’s biggest clinical trial is for one of the cheapest drugs

By
October 22, 2015
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Finance

Forget the plunging stock price, here’s Valeant’s biggest problem

By
October 22, 2015
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Health

Short-seller: Is Valeant the pharmaceutical Enron?

By
October 21, 2015
519891667
Health

Drug companies are paying huge sums to fast-track FDA approval

By
October 20, 2015
MSMB Capital Management CIO Martin Shkreli
Leadership

The face of high drug prices is trolling Bernie Sanders on Twitter

By
October 19, 2015
Marco Rubio
Leadership

Marco Rubio calls out high drug prices

By
October 19, 2015

Most Popular